1. Introduction {#s0010}
===============

Disease emergence presents a significant risk to the conservation of endangered wildlife. The risks of disease are leading to growing concern of the cost--benefit efficiency of the supplementation strategy ([@bib0090]). Species recovery actions such as the supplementation of dwindling populations with captive bred animals may introduce parasites atypical to the recovery species or exacerbate prevalence of existing pathogens due to stress and immune status of captive bred individuals, which may spread these pathogens into its new environment ([@bib0110; @bib0035]). Control of disease risks requires a sound understanding of host--parasite interactions, both in threatened species and of hosts that may contribute to disease emergence. Further, parasites specific to the target species may not survive translocation or other conservation processes, thereby unbalancing the natural host--parasite relationship ([@bib0115]).

*Cryptosporidium*, a protozoan parasite with a broad vertebrate host range and variable host specificity, represents a potential indicator of disease risks associated with conservation management. This research strategy is particularly applicable to threatened Australian marsupials where the occurrence of human derived *Cryptosporidium* species has not been conclusively determined ([@bib0080; @bib0125; @bib0050]).

Of the 26 described *Cryptosporidium* species (reviewed in [@bib0185]), twelve have been reported in both humans and other hosts: *C. parvum, C. hominis, C. ubiquitum, C. andersoni, C. bovis, C. cuniculus, C. muris*, *C. canis, C. felis, C. meleagridis, C. suis* and *C. fayeri* ([@bib0245; @bib0075; @bib0240; @bib0100; @bib0170; @bib0220]). Each of the *Cryptosporidium* species reported in humans have been found in the Australian environment ([@bib0175; @bib0010; @bib0130]), though human infections in Australia are predominantly *C. parvum* and *C. hominis* ([@bib0225]).

Despite *Cryptosporidium* being identified in 16 marsupial species from 7 families (reviewed in [@bib0135] and [@bib0140]), identifications of *Cryptosporidium* to species level is limited to recent studies employing molecular tools ([@bib0230; @bib0080; @bib0145; @bib0180; @bib0260]). Following molecular identification, marsupials were found to be susceptible to two host-adapted *Cryptosporidium* species, *C. fayeri* and *C. macropodum* ([@bib0145; @bib0180]). Several other host-specific genotypes have also been described in marsupials including brushtail possum genotype I from brushtail possums (*Trichosurus vulpecula*) ([@bib0080]) and kangaroo genotype I from western grey kangaroos (*Macropus fuliginosus)* ([@bib0260])*.*

Although there are reports of *C. parvum* and *C. hominis* in marsupials, these are based only upon a molecular signature from a faecal DNA sample, and an infection has never been confirmed using other methods such as parasite isolation ([@bib0080; @bib0125; @bib0050]). The molecular detection of *C. parvum* and *C. hominis* in marsupial hosts has also been associated with an inability to confirm at greater than a single locus, namely the 18S rRNA. Passage of *C. parvum* of *C. hominis* oocysts through the marsupial gut is the likely reason for identifications of these *Cryptosporidium* species in marsupials ([@bib0050]). The only confirmed case of *Cryptosporidium* infection in a marsupial that was not host specific was an infection of *C. muris* in captive greater bilbies (*Macrotis lagotis*) being bred for release into natural habitat ([@bib0230]).

Here we use molecular methods to detect and identify *Cryptosporidium* in the brush-tailed rock-wallaby (BTRW), *Petrogale penicillata*. This species is listed as 'endangered' in New South Wales, Australia (NSW *Threatened Species Conservation Act* 1995) and 'near threatened' on the IUCN Red List of Threatened Species across eastern Australia ([@bib0085]). There is an approved NSW Recovery Plan for the species ([@bib0040]), as well as an approved National Recovery Plan ([@bib0105]). These plans identify supplementation of small colonies with captive bred individuals as an important recovery strategy and over the last few years several translocations of individuals between captive breeding facilities and wild populations have occurred ([@bib0105]). As rock-wallaby populations have experienced variable levels of human intervention, studying their parasites provides a platform to examine the effect of conservation management on the host--parasite relationship. Hence, our aim was to detect and identify *Cryptosporidium* species infecting wild, captive bred, and supplemented brush-tailed rock-wallaby populations.

2. Methods {#s0015}
==========

2.1. Sample collection and sites {#s0020}
--------------------------------

Brush-tailed rock-wallabies were once abundant in south-eastern Australia but are now reduced to fragmented populations in New South Wales and Victoria ([@bib0055]). Dispersal between populations, which are located in steep, rocky habitats, is rare ([@bib0025]). For this study, seven BTRW sites were sampled between March 2010 and July 2013 ([Table 1](#t0010){ref-type="table"}). Sample collection dates were spread evenly across three seasons (Autumn, Summer and Winter), with \~10 samples collected in Spring (2010 and 2012), spread evenly across the four years. The origin of each population varied and included three categories: one site with a BTRW population kept in a captive breeding facility (captive bred), sites where free-ranging populations had been supplemented with captive bred individuals (supplemented) and two pristine sites with only free-ranging animals (wild). Fresh faecal samples were collected in vials containing silicon beads from each site opportunistically from unknown individuals during routine colony management by the Office of Environment and Heritage staff and were then stored at 4 °C until further processing. The highest number of samples was obtained from Square Top in Warrumbungle National Park since this was a major release site.

2.2. DNA extraction and PCR screening {#s0025}
-------------------------------------

Genomic DNA was extracted from faecal material (\~150 mg) using the ISOLATE Fecal DNA kit (Bioline, London, UK) following manufacturer\'s instructions. The extracted DNA was stored at −20 °C until further analysis. Directly prior to each PCR, the DNA samples were treated with GeneReleaser (BioVentures, Inc., TN, USA) by combining equal volumes of DNA and GeneReleaser, and subjecting the mixture to 7 min in a 500 W microwave.

2.3. PCR screening at the 18S rRNA locus {#s0030}
----------------------------------------

DNA samples were initially screened for *Cryptosporidium* using nested PCR to amplify a partial fragment of the 18S rRNA. The primary reaction followed the methodology of [@bib0255] but with a lower MgCl~2~ concentration (2 mM). The secondary reaction comprised the primers 18S IF and 18S IR and followed the method of [@bib0120]. PCRs were performed using Red Hot Taq DNA polymerase (ThermoFisher Scientific, Waltham, MA, USA) as previously described ([@bib0080]). Both reactions were modified to increase specificity for *Cryptosporidium* by lowering the concentration of dNTPs to 50 µM.

Longer 18S rRNA fragments were generated for samples testing positive for *Cryptosporidium* using the 18S IF and 18s IR primer set. The longer fragments were amplified using the primers of [@bib0255] for both primary and secondary reactions, following conditions as previously described by [@bib0225]), inclusive of dNTPs and MgCl~2~ concentrations as described above.

2.4. PCR amplification at confirmatory loci {#s0035}
-------------------------------------------

To confirm 18S rRNA positives, DNA samples were screened at two additional loci, actin and glycoprotein 60 (*gp60*). For the actin locus, a nested protocol ([@bib0205]) was performed with minor modifications. To improve specificity for *Cryptosporidium,* the concentration of MgCl~2~ was lowered to 2 mM, dNTPS to 50 µM, and the annealing temperature raised to 54 °C in the secondary reaction. All amplifications were performed using Red Hot Taq DNA Polymerase.

Amplification of the *gp60* locus was achieved using a nested protocol with primary amplification achieved using the primers outF and outR ([@bib0160]) and secondary reactions using ATGF and StopR ([@bib0215]). Red Hot Taq was used for both amplifications. All PCR reactions performed included a negative control (H~2~O) and a positive control of DNA extracted from purified oocysts of *C. parvum*.

2.5. Sequencing of positive samples {#s0040}
-----------------------------------

All amplicons generated for 18S rRNA, actin and *gp60* were sequenced to enable *Cryptosporidium* species identification. Amplicons from each of the four PCRs which contained a band of the expected size when resolved by electrophoresis (2% agarose in TBE with SYBR Green staining) were purified using the QIAQuick PCR purification kit (Qiagen, Venlo, the Netherlands). Purified amplicons were sequenced in both directions (Macrogen, Seoul, Korea) using appropriate primers for amplifications, with the exception of the short fragment of the 18S rRNA, which were only sequenced with the primer 18S IF ([@bib0120]).

2.6. Sequencing and phylogenetic analyses {#s0045}
-----------------------------------------

The sense and antisense sequence fragments for each locus were aligned with Geneious (version 6.1.7, Biomatters LtD, New Zealand) and manually examined for quality and read errors. Consensus sequences for each positive sample were extracted and searched against GenBank using BlastN function in Geneious. To enable species identification within a phylogenetic framework, samples positive for 18S rRNA (\~825 bp) were trimmed to the same length and aligned with *Cryptosporidium* reference sequences from GenBank using Clustal W ([@bib0095]). A phylogenetic tree was constructed based on this alignment using neighbour-joining. Sequences generated in this study have been submitted to GenBank under accession numbers KP730299-KP730329.

2.7. Statistical analysis {#s0050}
-------------------------

To test differences of *Cryptosporidium* detection rate between sites and site categories, samples were tested at the 18S rRNA (\~298 bp) locus for presence or absence and checked for significant differences with a chi-square test in Minitab (version 17.1.0, Minitab Inc.).

3. Results {#s0055}
==========

3.1. *Cryptosporidium* screening {#s0060}
--------------------------------

DNA was extracted from 324 samples and screened for *Cryptosporidium* using 18S rRNA PCR. Of the 324 screened faecal samples, 43 contained the expected amplicon. DNA sequencing and Blast searches identified 23 samples as being *Cryptosporidium,* giving a total positive identification rate of 7.1% in BTRW. *Cryptosporidium* positive samples were obtained from three site types (captive bred, supplemented and wild). Positives were found to be present across most study sites except for Jenolan Caves. There was no significant difference in *Cryptosporidium* detection between captive-bred, wild and supplemented as categories (χ^2^ = 3.811, DF = 2, p = 0.149). However, there was a significant difference between the sites (χ^2^ = 23.6, DF = 6, p \< 0.001). Kangaroo Valley Creek had the highest rate of positive samples (40%), but this site had the lowest amount of samples tested (n = 10; [Table 1](#t0010){ref-type="table"}).

3.2. Species identification at the 18S rRNA locus {#s0065}
-------------------------------------------------

From the initial positive samples (n = 23), 20 samples yielded sequence data for the larger 18S rRNA fragment (825 bp), which was used to generate a phylogeny ([Fig. 1](#f0015){ref-type="fig"}). Four samples from supplemented sites and three samples from wild sites clustered with the *C. parvum* and *C. hominis*. Three samples from supplemented sites, one from a captive bred site and one from a wild site grouped with the marsupial-specific species *C. fayeri* and *C. macropodum*. A further four samples from a wild site and one from a captive-bred site grouped with *C. meleagridis*. Two samples from a wild site were grouped with *C. ubiquitum*.

3.3. Species confirmation using actin and *gp60* {#s0070}
------------------------------------------------

Sequence analysis at the actin and *gp60* loci resulted in amplicons and sequence data from only eight samples across all loci ([Table 2](#t0015){ref-type="table"}). At the actin locus, although 15 samples generated a band of the expected size (\~1066 bp), only four were identified using BlastN searches as *Cryptosporidium*, with two samples being *C. fayeri* and two being *C. meleagridis*. For *gp60*, seven samples generated an amplicon with three samples assigned to *C. fayeri* and four to *C. meleagridis* ([Table 2](#t0015){ref-type="table"}). However, the four samples from Kangaroo Valley Mountain identifying as *C. meleagridis* may represent the same individual sampled twice over two time points. For those samples identified at the 18S rRNA as *C. hominis* and *C. parvum*, neither actin nor *gp60* could be amplified. An exception was sample 973 identified as *C. hominis* at the 18S rRNA and *C. fayeri* by *gp60* sequencing.

4. Discussion {#s0075}
=============

The level of detection of *Cryptosporidium* in BTRW (7.1%) is consistent with observations of *Cryptosporidium* in other marsupials which range between 6.7% and 12.2% ([@bib0155; @bib0080; @bib0260; @bib0050]). Here, *Cryptosporidium* detection in BTRW is based on sequence identifications using a 298 bp fragment of the 18S rRNA. PCR is commonly employed for detection of *Cryptosporidium* in faecal samples as this approach has greater sensitivity than microscopy, both in detection and identification of species ([@bib0065; @bib0150; @bib0180; @bib0050]). In our study, a larger fragment (\~825 bp) failed to amplify three samples confirmed as *Cryptosporidium* using the smaller fragment, indicating that selection of optimal amplification methods should be considered when undertaking molecular detection of this parasite.

Despite no significant difference in the detection of *Cryptosporidium* between captive bred and free ranging animals, the identity of *Cryptosporidium* species in BTRW determined by sequencing raises concern for the health status of captive and wild BTRW. *Cryptosporidium fayeri* has previously been identified in six marsupial hosts including the related yellow-footed rock-wallaby *P. xanthopus* ([@bib0120; @bib0150; @bib0160; @bib0180; @bib0140; @bib0260; @bib0130]). *Cryptosporidium fayeri* does not appear to cause disease in marsupials ([@bib0180]). *Cryptosporidium meleagridis* has been identified in a range of vertebrates, including avian and mammalian hosts, as well as humans ([@bib0015; @bib0250]). While *C. meleagridis* is the most common infection of *Cryptosporidium* in humans after *C. parvum* and *C. hominis* ([@bib0060]), human infections are rare in Australia ([@bib0225]). Consequently, it is unlikely that the captive bred animals were infected from human sources, but by other host species, such as free ranging birds, inhabiting the captive breeding site. The wild site, where most of the *C. meleagridis* isolates were found, is secluded from humans and thus transmission between humans and BTRW is unlikely. This is supported by the *gp60* analysis.

The *C. meleagridis gp60* sequences from BTRW isolates displayed greater genetic similarity to *gp60* sequences from avian hosts ([@bib0200]), yet they were distinct from described sequences, indicating a new *gp60 C. meleagridis* subtype. This finding is the first report where a zoonotic species of *Cryptosporidium* was confirmed across multiple loci in a wild marsupial host. As such, much is unknown about the diversity and pathogenicity of *C. meleagridis* in wild marsupials and thus further study is required to understand the extent to which this species has penetrated marsupial hosts and likely transmission routes.

*Cryptosporidium parvum* and *C. hominis* were also identified in BTRW samples; however, these identifications were only possible at a single locus, the 18S rRNA. Only one of these samples could be amplified at one of the two confirmatory loci where it was typed as *C. fayeri*. Both *C. parvum* and *C. hominis* have been reported in a range of marsupials but similar to this study, other studies also failed to confirm identifications at loci other than the 18S rRNA ([@bib0080; @bib0125; @bib0050]). Some isolates were inferred to be *C. ubiquitum* and *C. macropodum* through a GenBank match at the 18S rRNA locus but failed to amplify at subsequent loci ([Fig. 1](#f0015){ref-type="fig"}). While *C. macropodum* is specific to marsupials, particularly macropods ([@bib0145]), *C. ubiquitum* is typical to cattle but is commonly identified in humans as well ([@bib0070]). So far, no report has been made of *C. ubiquitum* in marsupials ([@bib0175]).

Failure to amplify *C. parvum* and *C. hominis* isolates from marsupials at other loci has been attributed to low numbers of oocysts and the multi copy nature of the 18S rRNA locus compared to single copy confirmatory loci ([@bib0080; @bib0160; @bib0125]). Indeed, oocyst counts in possums and bandicoots confirm low oocyst numbers ([@bib0080; @bib0050]). The question remains if the presence of these human infective species is merely passage of oocysts through the marsupial gut or a true infection. Whole genome amplification could be employed to boost amplification of low oocyst numbers. This method has previously proved successful on clinical samples of *C. parvum* and *C. hominis* across three loci ([@bib0020]). Identification at the 18S rRNA locus alone has been found to underestimate mixed infections as this technique preferentially amplifies a predominant genotype ([@bib0165]). Mixed infections of *Cryptosporidium* were considered rare but they have only been studied so far in humans, mainly AIDS patients ([@bib0030]) and children ([@bib0245]), and in calves ([@bib0210]). The role of mixed infections in *Cryptosporidium* pathology is still unclear. No study has so far described mixed infections in marsupials ([@bib0175]). The difficulty to amplify at discriminatory loci for genotypes such as *C. parvum* in marsupials highlights the need to identify *Cryptosporidium* using a multi-locus approach.

Another difficulty encountered in this study was the potential for pseudo-replication. When working with an endangered species one encounters issues with sample collection and numbers available for stringent analyses. For instance, the Kangaroo Valley Mountain population is estimated to comprise less than 10 individuals. As we identified *C. meleagridis* in four samples from Kangaroo Valley Mountain collected over two sampling periods, it is possible that the same individual has been sampled multiple times. A possible solution to reduce bias relative to sampling would be to apply microsatellite (MSAT) analysis to identify individuals. This method has been widely applied to many species ranging from large carnivores to small marsupials using faecal DNA, to monitor threatened populations, analyse their genetic diversity and wide-scale demographics of large populations ([@bib0195; @bib0045; @bib0235]).

The findings in this study suggested that there was no direct effect of captive breeding and translocation on *Cryptosporidium* in brush-tailed rock-wallabies. In Australia, translocation policies are developed by the representative State bodies, and veterinary screening is not mandated but is increasingly employed to monitor the health of captive bred animals before release ([@bib0190]). Health screening and its relation to the success of a recovery program is further complicated by a diverse number of potential pathogens and a lack of baseline data on risks that selected pathogens may pose to wildlife species. If unusual parasite species atypical to the host group are found, such as *C. meleagridis* in BTRW, consideration as to whether the animal should be used for translocation or isolated from the population would form part of the management response. The pathology of *Cryptosporidium* in wild marsupials is also currently unknown (reviewed in [@bib0175]), making such a risk assessment difficult for BTRW. The identification of *Cryptosporidium* species with varying host specificity found in both captive bred and wild brush-tailed rock-wallabies indicates that further research is required into the diversity and pathology of this parasite in Australian wildlife.
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![Samples were identified within a phylogenetic framework with the tree constructed using neighbour-joining with bootstrap test (1,000 replicates, displayed at nodes) using the 18S rRNA locus (878 bp). KV denotes Kangaroo Valley.](ijppaw102-fig-0001){#f0015}

###### 

The rate of *Cryptosporidium* detected at the different loci per screened site and site category. All sites are in New South Wales; the precise location is withheld for some sites for the safety of the animals. KV means Kangaroo Valley. Samples at the loci (18S rRNA, actin and *gp60*) were deemed as positive after DNA sequencing.

  Site                Population category                             No. of samples   18S rRNA (298 bp)   18S rRNA (825 bp)   Actin   *gp60*
  ------------------- ----------------------------------------------- ---------------- ------------------- ------------------- ------- --------
  KV Mountain         Wild                                            55               7                   7                   2       3
  KV River            Supplemented                                    43               2                   1                   0       1
  KV Creek            Supplemented                                    10               4                   3                   0       0
  Nattai              Wild                                            30               3                   3                   1       1
  Square Top          Supplemented                                    123              5                   4                   0       0
  Waterfall Springs   Captive bred[a](#tn0010){ref-type="table-fn"}   39               2                   2                   1       2
  Jenolan Caves       Supplemented                                    24               0                   0                   0       0

Wallabies in a captive breeding facility.

###### 

Species identification across three loci (18S rRNA, actin and *gp60*) for the samples positive at the 18S rRNA locus for *C. fayeri* and *C. meleagridis*. Samples identified at the 18S rRNA locus as other *Cryptosporidium* species ([Fig. 1](#f0015){ref-type="fig"}) were omitted from this table since they could not be amplified at other loci. NP indicates no product was amplified. KV means Kangaroo Valley.

  Label BW \#   Location            Site type      18S rRNA (298 bp)   \% Similarity   18S rRNA (825 bp)   \% Similarity   Actin              \% Similarity   *gp60*                             \% Similarity
  ------------- ------------------- -------------- ------------------- --------------- ------------------- --------------- ------------------ --------------- ---------------------------------- ---------------
  613           Waterfall Springs   Captive bred   *C. fayeri*         99.6%           *C. fayeri*         99.5%           *C. fayeri*        99.9%           *C. fayeri* (subtype A10)          99.7%
  666           KV Mountain         Wild           *C. meleagridis*    99.2%           *C. meleagridis*    99.9%           NP                 NP              NP                                 NP
  669           KV Mountain         Wild           *C. meleagridis*    99.8%           *C. meleagridis*    99.6%           *C. meleagridis*   99.9%           *C. meleagridis* (subtype IIIgA)   91.4%
  689           KV Mountain         Wild           *C. meleagridis*    99.6%           *C. meleagridis*    99.9%           *C. meleagridis*   99.7%           *C. meleagridis* (subtype IIIgA)   91.2%
  691           KV Mountain         Wild           *C. meleagridis*    99.2%           *C. meleagridis*    99.7%           NP                 NP              *C. meleagridis* (subtype IIIgA)   91.6%
  735           Waterfall Springs   Captive bred   *C. meleagridis*    99.1%           *C. meleagridis*    99.8%           NP                 NP              *C. meleagridis* (subtype IIIbA)   88.8%
  973           KV River            Supplemented   *C. hominis*        100.0%          NP                  NP              NP                 NP              *C. fayeri* (subtype A10)          99.9%
  993           Nattai              Wild           *C. fayeri*         99.6%           *C. fayeri*         99.4%           *C. fayeri*        99.4%           *C. fayeri* (subtype A7)           99.8%
